Cloud-Clone Attended 2018 AACR
On April 16-18th, 2018, the American Cancer Research Association (AACR) hosted the 2018 annual meeting of the American Cancer Research Conference in Chicago. Cloud-Clone and more than 20,000 experts and scholars from more than 50 countries and regions around the world, drug R&D personnel, clinicians and more than 400 enterprises to join together to exchange the research results of advanced cancer drugs for 2018.
At the exhibition, Cloud-Clone not only showed researchers the latest technical products in the field of corporate cancer research, such as CRISPR/CAS9 technology platform, KO-validated antibody, CAR-T research and other reagents, as well as communicated with several hundreds of scientists, clinical researchers and staff from biotech companies. Everybody discussed the latest trend in the development of scientific research market together. During the communication with several Biotech companies and research institutions, we introduced our special products and services, and excavated each other's opportunities for cooperation. During the exhibition, the exhibition of Cloud-Clone received great attention from the participants.